Taro Pharmaceutical Industries Ltd.

TARO · NYSE
Analyze with AI
$42.98+$0.005 (+0.01%)
At close:Jun 21, 2024, 7:59 PM UTC
P/E TTM29.99
P/B TTM0.9
P/S TTM2.57
Dividend Yield0%
EPS$1.43
Beta0.557
Valuation
PEG Ratio0.30
FCF Yield4.84%
EV / EBITDA32.61
Quality
ROIC0.78%
Gross Margin48.47%
Cash Conv. Ratio2.42
Growth
Revenue 3Y CAGR3.88%
FCF Growth462.25%
Safety
Net Debt / EBITDA-9.45
Interest Coverage0.00
Efficiency
Inventory Turnover1.58
Cash Conv. Cycle283.26

Taro Pharmaceutical Industries Ltd. (TARO) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Taro Pharmaceutical Industries Ltd. (TARO) stock price today?

As of Jun 21, 2024, 7:59 PM UTC, Taro Pharmaceutical Industries Ltd. (TARO) stock is trading at $42.98. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date TARO stock quotes for informed trading decisions.

What is Taro Pharmaceutical Industries Ltd.'s market capitalization?

Taro Pharmaceutical Industries Ltd. (TARO) has a market capitalization of approximately $1.6B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Taro Pharmaceutical Industries Ltd.'s size relative to other companies in the USD market. The market cap figure updates automatically as the TARO stock price changes.

What is the 52-week range for Taro Pharmaceutical Industries Ltd. stock?

Taro Pharmaceutical Industries Ltd. (TARO) stock has traded in a 52-week range of $32.67 — $45.76. The 52-week range shows the highest and lowest prices at which TARO traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Taro Pharmaceutical Industries Ltd. stock price to this range provides context for recent price action.

How much trading volume does Taro Pharmaceutical Industries Ltd. stock have?

Taro Pharmaceutical Industries Ltd. (TARO) stock recently traded approximately 147.1K shares. Trading volume indicates market liquidity and investor interest in TARO. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Taro Pharmaceutical Industries Ltd. stock.

Does Taro Pharmaceutical Industries Ltd. pay dividends to shareholders?

Yes, Taro Pharmaceutical Industries Ltd. (TARO) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Taro Pharmaceutical Industries Ltd. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Taro Pharmaceutical Industries Ltd.'s intraday price range?

Today, Taro Pharmaceutical Industries Ltd. (TARO) stock has traded in a range of $42.94 — $42.98. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring TARO's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Taro Pharmaceutical Industries Ltd. stock data?

AlphaPilot sources real-time TARO stock quotes, fundamental financial data, and historical price charts for Taro Pharmaceutical Industries Ltd. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Taro Pharmaceutical Industries Ltd. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of TARO stock performance.